References
- Park SK, Sakoda LC, Kang D, Chokkalingam AP, Lee E, Shin HR, et al. Rising prostate cancer rates in South Korea. Prostate 2006;66:1285-1291 https://doi.org/10.1002/pros.20419
- Koutsilieris M. Skeletal metastases in advanced prostate cancer: cell biology and therapy. Crit Rev Oncol Hematol 1995;18:51-64 https://doi.org/10.1016/1040-8428(94)00122-A
- Long MA, Husband JE. Features of unusual metastases from prostate cancer. Br J Radiol 1999;72:933-941 https://doi.org/10.1259/bjr.72.862.10673942
- Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000;31:578-583 https://doi.org/10.1053/hp.2000.6698
- Moura FM, Garcia LT, Castro LP, Ferrari TC. Prostate adenocarcinoma manifesting as generalized lymphadenopathy. Urol Oncol 2006;24:216-219 https://doi.org/10.1016/j.urolonc.2005.06.022
- McGarry RC. Superior vena cava obstruction due to prostate carcinoma. Urology 2000;55:436
- Kosugi S, Mizumachi S, Kitajima A, Igarashi T, Hamada T, Kaya H, et al. Prostate cancer with supraclavicular lymphadenopathy and bulky abdominal tumor. Intern Med 2007;46:1135-1138 https://doi.org/10.2169/internalmedicine.46.0014
- Alanen KA, Kuopio T, Koskinen PJ, Nevalainen TJ. Immunohistochemical labelling for prostate specific antigen in non-prostatic tissues. Pathol Res Pract 1996;192:233-237 https://doi.org/10.1016/S0344-0338(96)80226-3
- Effert PJ, Bares R, Handt S, Wolff JM, Bull U, Jakse G. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol 1996;155:994-998 https://doi.org/10.1016/S0022-5347(01)66366-3